BridgeMD
New treatment option for Breast Cancer
Official title Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer
ClinicalTrials.gov ID: NCT07146295
What this study is testing
What is Technetium (99mTc)?
Technetium (99mTc) is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for breast cancer.
Also referred to as 99mTc, Technetium-99m labelled nanocolloid.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn how to successfully introduce a new method for finding the sentinel lymph node during breast cancer surgery into routine hospital care. The method uses a dye called indocyanine green (ICG) and a special camera to see the lymph node.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients ≥ 18 years old.
- DCIS or invasive breast cancer, confirmed by biopsy
- Clinically node-negative, confirmed by preoperative axillary ultrasound
- Indication for breast cancer surgery with SLN procedure via axillar incision
You likely can't join if
- Combined MARI procedure
- Known allergy for Indocyanine Green (ICG), intravenous contrast or iodine
- History of axillary lymph node dissection
- Hyperthyroidism or thyroid cancer
- Pregnancy or breast-feeding
- No written informed consent according to ICH/GCP and national regulations.
The study team makes the final eligibility decision.
Where it's taking place
- Alkmaar, Netherlands
- Hengelo, Netherlands
- Hoofddorp, Netherlands
- Hoorn, Netherlands
- Leiden, Netherlands
- Nijmegen, Netherlands
- Utrecht, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alkmaar, Netherlands; Hengelo, Netherlands; Hoofddorp, Netherlands; Hoorn, Netherlands; Leiden, Netherlands; Nijmegen, Netherlands and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.